IASLC ✓

@IASLC · Denver, CO · joined 29 Jul 2009

The International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer. #LCSM

21 122Followers

2 074Following

14 905Posts total

5.4KViews on collected posts

Against accounts of the same size

7 posts from the last 90 days, next to the 10K–100K follower range. right around the median for its follower range.

Median views797this account1 637median for 10K–100K

Reach, %3.77%this account5.01%median for 10K–100K

Engagement, %1.85%this account1.81%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	797	1 637	0.49×
Reach (views ÷ followers)	3.77%	5.01%	0.75×
Engagement rate	1.85%	1.81%	1.02×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.9K2 Sep

8203 Sep

797

756

1.1K4 Sep

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.33%2 Sep

2.56%3 Sep

1.63%

1.85%

3.04%4 Sep

1.96%

0.00%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.81%.

What the audience does

Likes71.3%77 in total

Reposts21.3%23 in total

Replies1.9%2 in total

Quotes3.7%4 in total

Bookmarks1.9%2 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

@IASLC @ogarrieta @BenCreelan Congratulations @BenCreelan @MoffittNews! Very well deserved! 59 views · 0 likes · 0 reposts · 0 replies 04 Sep 2026 @IASLC @BenCreelan Congratulations @BenCreelan! 👏 So well deserved!! 51 views · 1 likes · 0 reposts · 0 replies 04 Sep 2026 Congratulations to IASLC Career Advancement Grant awardee @BenCreelan 🎉! His project will survey antigenic targets of T-cell immunity following ERBB2 oncogene-inhibitor therapy. We look forward to seeing the impact of his research! #LungCancerResearch #IASLC https://t.co/wzx9FD 1.1K views · 27 likes · 3 reposts · 2 replies 04 Sep 2026 The management of oligometastatic #LungCancer continues to evolve. Dr. @NarjustFlorezMD is joined by Drs. @YYElamin and Liliana Faroni to discuss patient selection, radiation, surgery, ctDNA and a more precise approach to care. 🎧 Listen: https://t.co/FdR6d2qtCX https://t.co/w8v 756 views · 9 likes · 4 reposts · 0 replies 03 Sep 2026 🫁 Celebrate 20 years of the Journal of Thoracic Oncology during #WCLC26. Discover more details in ILCN: https://t.co/FeZkTzHaqa #LCSM 797 views · 8 likes · 4 reposts · 0 replies 03 Sep 2026 What should the future of AI in #lungcancer care look like? IASLC wants to hear from those at the center of care: patients and health professionals. Take one of our new surveys and add your perspective to the conversation. 👤 Patients: https://t.co/i3VgBV9bLE 🩺 Health https://t 820 views · 14 likes · 6 reposts · 0 replies 03 Sep 2026 👟 Hit the ground running at #WCLC26 with this guide to navigating Seoul. Find out more in ILCN: https://t.co/drFbwZK7OZ #LCSM 1.9K views · 18 likes · 6 reposts · 0 replies 02 Sep 2026